1. GPCR/G Protein
  2. Prostaglandin Receptor
  3. PF-04475270

PF-04475270 is a prodrug of CP-734432 (HY-119236), as well as an agonist of the EP4 prostaglandin receptor, with IC50 values of 2 nM and 8 nM against human and canine sources, respectively. PF-04475270 is rapidly hydrolyzed into its active metabolite CP-734432 by ocular esterases or corneal homogenate, stimulates cAMP production, and activates cAMP response element-mediated β-lactamase activity in cells expressing EP4. PF-04475270 can be used in research related to glaucoma.

For research use only. We do not sell to patients.

PF-04475270

PF-04475270 Chemical Structure

CAS No. : 1201925-19-0

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Prostaglandin Receptor Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

PF-04475270 is a prodrug of CP-734432 (HY-119236), as well as an agonist of the EP4 prostaglandin receptor, with IC50 values of 2 nM and 8 nM against human and canine sources, respectively. PF-04475270 is rapidly hydrolyzed into its active metabolite CP-734432 by ocular esterases or corneal homogenate, stimulates cAMP production, and activates cAMP response element-mediated β-lactamase activity in cells expressing EP4. PF-04475270 can be used in research related to glaucoma[1][2].

IC50 & Target[1]

hEP4

2 nM (IC50)

dog EP4

8 nM (IC50)

In Vitro

PF-04475270 crosses cornea tissue more robustly than its active metabolite CP-734432[1].
PF-04475270 (10 μM) is rapidly converted to CP-734432 in rabbit corneal homogenates[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

PF-04475270 (0.1-5 μg; topical administration; single instillation; 0.5-1.25 μg; topical administration; once daily; for 4 consecutive days) reduces intraocular pressure (IOP) in normotensive beagle dogs, with a better IOP-lowering effect observed after single administration[1][2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Beagle dogs (male and female)[1][2]
Dosage: 0.1 μg; 0.25 μg; 2.5 μg; 5 μg (single dose); 0.5 μg; 1.25 μg (once daily for 4 days)
Administration: topical; single instillation (for 0.1 μg, 0.25 μg, 2.5 μg, 5 μg); once daily; 4 days (for 0.5 μg, 1.25 μg)
Result: Achieved mean IOP of 73% of baseline at 24 hours post-first dose, 67% of baseline at 48 hours, 65% of baseline at 72 hours, and 65% of baseline at 96 hours for the 0.5 μg multiple-dose group.
Achieved mean IOP of 81% of baseline at 24 hours post-first dose, 64% of baseline at 48 hours, 61% of baseline at 72 hours, and 58% of baseline at 96 hours for the 1.25 μg multiple-dose group.
Demonstrated progressively greater IOP reduction with repeated daily dosing despite no accumulation of the active metabolite CP-734432 in ocular tissues.
Showed a population-based pharmacokinetic-pharmacodynamic model (model II) with a positive feedback loop captured time-dependent IOP lowering, with key parameters including a SC50 of 0.674 ng/g, a Sₘₐₓ of 0.287, and a kₘₒd of 0.029 h-1.
Molecular Weight

511.60

Formula

C26H32F3NO4S

CAS No.
SMILES

FC(F)(F)C1=CC=CC(C[C@H](O)CC[C@@H]2N(C(CC2)=O)CCCC3=CC=C(C(OC(C)C)=O)S3)=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
PF-04475270
Cat. No.:
HY-185643
Quantity:
MCE Japan Authorized Agent: